DMAA:NASDAQ, Drugs Made In America Acquisition Corp.

DMAA stock overview

Drugs Made In America Acquisition Corp. (DMAA:NASDAQ) closed at $10.90 on November 17, 2026, unchanged on the day. The stock trades 0.1% below its 52-week high of $10.91 and 5.6% above its 52-week low of $10.32. Over the past year, it gained 5.5%. Drugs Made In America Acquisition Corp. is part of the Funds & Shells sector.

Key figures

Price
$10.90
Day change
0.00%
Volume
416
Average volume
22,064
Market cap
264M+
52-week range
$10.32 – $10.91
50-day average
$10.87
200-day average
$10.66

Price action over the past year

In 252 trading sessions since November 17, 2025, DMAA closed higher on 95 days (38%). Its best day was March 20, 2026 (+0.48%) and its worst was October 7, 2026 (-0.46%). It never moved 10% or more in a single session.

Recent signals

Similar stocks

Find more stocks like DMAA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.